Weleader Biomedical Co (ROCO:7713) Short-Term Debt: NT$0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7713 Weleader Biomedical Co Ltd ROCO:7713
66 GF Score
Price NT$71.00
GF Value NT$74.61
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Weleader Biomedical Co Short-Term Debt?

Weleader Biomedical Co ROCO:7713 -0.14% 66 Short-Term Debt is NT$0 Mil as of Jun. 2026. GuruFocus rates ROCO:7713 with a GF Score™ of 66/100 and a GF Value™ of NT$74.61 (Fairly Valued). The stock has 5 warning signs investors should review.

Weleader Biomedical Co's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$0 Mil.

Weleader Biomedical Co's quarterly Short-Term Debt declined from Dec. 2025 (NT$12 Mil) to Mar. 2026 (NT$1 Mil) and declined from Mar. 2026 (NT$1 Mil) to Jun. 2026 (NT$0 Mil).

Weleader Biomedical Co's annual Short-Term Debt increased from Dec. 2023 (NT$74 Mil) to Dec. 2024 (NT$97 Mil) but then declined from Dec. 2024 (NT$97 Mil) to Dec. 2025 (NT$12 Mil).

Weleader Biomedical Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Weleader Biomedical Co Short-Term Debt Related Terms

Weleader Biomedical Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Weleader Biomedical Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Weleader Biomedical Co Short-Term Debt Chart

Weleader Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 69.54 136.05 73.97 97.44 11.56

Weleader Biomedical Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.48 74.60 11.56 1.03 0.00
ROCO:7713
66GF Score
Weleader Biomedical Co Ltd ROCO:7713
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$0 Mil mean?
Weleader Biomedical Co (ROCO:7713) has a Short-Term Debt of NT$0 Mil as of Jun. 2026.
Is Weleader Biomedical Co's Short-Term Debt too high?
Weleader Biomedical Co's current Short-Term Debt is NT$0 Mil. Overall, Weleader Biomedical Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Weleader Biomedical Co's Short-Term Debt compare to ABT and SYK?
Weleader Biomedical Co's Short-Term Debt of NT$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Weleader Biomedical Co's current Short-Term Debt is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weleader Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Weleader Biomedical Co (ROCO:7713) is currently considered Fairly Valued. The stock's GF Value™ is NT$74.61, compared to a current price of NT$71.00 — trading 4.8% below its estimated fair value. The current Short-Term Debt is NT$0 Mil. Weleader Biomedical Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Weleader Biomedical Co (ROCO:7713), the current Short-Term Debt is NT$0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Weleader Biomedical Co (ROCO:7713) Overvalued in 2026?

Based on GuruFocus' analysis, Weleader Biomedical Co stock appears to be undervalued. The current stock price of NT$71.00 is trading 4.8% below its estimated GF Value™ of NT$74.61. GuruFocus considers Weleader Biomedical Co to be Fairly Valued.

Key valuation signals for ROCO:7713:

  • Short-Term Debt: NT$0 Mil
  • GF Value™: NT$74.61 vs. price of NT$71.00 (4.8% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ROCO:7713 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Weleader Biomedical Co Business Description

Address No. 80, Minzu 1st Road, 19th Floor - 1 & 2, Sanmin District, Kaohsiung, TWN
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments. The reportable segments of the Group are: The Company, which includes sale of testing reagents, and provision of testing instruments and services; and Health Leader, which includes sale of dietary supplements and testing reagents, and provision of information and professional services. It derives majority revenue from the Company segment. Geographically, the company operates and generates revenue from Taiwan.
66GF Score

Get the complete analysis for ROCO:7713

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.00
Price
NT$74.61
GF Value